EC Number   |
Expression |
Reference |
|---|
  3.4.21.122 | down |
deficiency or pharmacological inhibition of the cellular lysine-methyltransferase SMYD2 decreases TMPRSS2 expression on both mRNA and protein levels |
764448 |
| 3.4.21.122 | down |
down-regulated in androgen-independent prostate cancer xenograft tissue derived from a bone metastasis |
764399 |
| 3.4.21.122 | down |
ECRS patients with type 2 inflammation show decreased ACE2 and TMPRSS2 expressions in their sinus mucosa |
763869 |
| 3.4.21.122 | more |
expression does correlate with SARS-CoV infection in the upper lobe of the lung |
754528 |
| 3.4.21.122 | more |
TMPRSS2 expression is regulated by androgens in vivo |
753135 |
| 3.4.21.122 | up |
dihydrotestosteron significantly induces the expression of TMPRSS2 protein in prostate cancer cell |
753143 |
| 3.4.21.122 | up |
expression is upregulated in livers with high hepatitis C virus loads |
753762 |
| 3.4.21.122 | up |
periodontitis increases TMPRSS2 expression in the cell membrane of gingival keratinocytes |
765257 |
| 3.4.21.122 | up |
TMPRSS2 expression increases with old age |
763809 |
| 3.4.21.122 | up |
TMPRSS2 expression is increased during alveolarization into adulthood |
765143 |
